Lu-PSMA-617
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lu-PSMA-617, covering 2024-02-07 to 2025-12-10. Get the full timeline:
Most recent: Clinical Trial Update: EBRT + Lu-PSMA for N1M0 Prostate Cancer [Phase 1]